These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 13884326)
1. [Fulminating bullous dermatitis caused by mesantoin]. DE LOS SANTOS J; FIGUEREDO R Arch Hosp Univ; 1961; 13():24-9. PubMed ID: 13884326 [No Abstract] [Full Text] [Related]
2. [Skin eruptions caused by new antiepileptics (mesantoin)]. WINKLER A Z Haut Geschlechtskr; 1952 Mar; 12(5):193-201. PubMed ID: 14951472 [No Abstract] [Full Text] [Related]
3. Dermatitis medicamentosa caused by mesantoin. GREENHOUSE JM; LEHR E Ill Med J; 1950 Jul; 98(1):18-22. PubMed ID: 15428029 [No Abstract] [Full Text] [Related]
4. Fulminating dermatitis bullosa medicamentosa due to mesantoin. RUSKIN DB J Am Med Assoc; 1948 Jul; 137(12):1031-5. PubMed ID: 18871859 [No Abstract] [Full Text] [Related]
6. [Case of generalized lymphadenopathy with high fever, diffuse dermal eruptions, eosinophilia and plasmocytosis due to the administration of an anticonvulsant (mesantoin)]. AKSOY M; DEVRIMEL H; ALPUSTUN H Turk Tip Cemiy Mecm; 1959 May; 25():273-9. PubMed ID: 13792274 [No Abstract] [Full Text] [Related]
7. [Mesantoin reaction simulating infection]. JONSSON M Nord Med; 1961 Mar; 65():408-11. PubMed ID: 13790648 [No Abstract] [Full Text] [Related]
8. Aplastic anaemia due to 3-methyl-5-phenyl-5-ethyl-hydantoin ("mesantoin"). WILLIAMS CM Clin Rep; 1960; 10():69-71. PubMed ID: 13785405 [No Abstract] [Full Text] [Related]
9. Occurrence of skin pigmentation during mesantoin therapy. HUNTER H; JENKINS D J Am Med Assoc; 1951 Oct; 147(8):744-8. PubMed ID: 14873548 [No Abstract] [Full Text] [Related]
10. Diphenylhydantoin sensitivity. A case with exfoliative dermatitis and atypical lymphocytes in the peripheral blood. RANTAKALLIO P; FURUHJELM U Ann Paediatr Fenn; 1962; 8():146-51. PubMed ID: 14490300 [No Abstract] [Full Text] [Related]
11. [Another case of aplastic anemia due to mesantoin]. WEINMANN O Wien Klin Wochenschr; 1951 Aug; 63(33):587-8. PubMed ID: 14877149 [No Abstract] [Full Text] [Related]
12. [Case of agranulocytosis occurring during mesantoin therapy of epilepsy]. RIGOTTI S Riv Neurol; 1951; 21(6):532-8. PubMed ID: 14942315 [No Abstract] [Full Text] [Related]
13. Fatal pancytopenia following the use of mesantoin; report of a case. WELLER RW; METCALFE J N Engl J Med; 1949 Jul; 241(1):17. PubMed ID: 18135085 [No Abstract] [Full Text] [Related]
14. [Bullous aminazin dermatitis]. KALAMKARIAN AA Zh Nevropatol Psikhiatr Im S S Korsakova; 1960; 60():593-4. PubMed ID: 14404077 [No Abstract] [Full Text] [Related]
15. [A case of scarlatinoform dermatitis produced by mesantoin administration]. DANIEL MARTINEZ P; GOMEZ OROZCO L Bol Med Hosp Infant Mex; 1950 Dec; 7(6):884-6. PubMed ID: 14848169 [No Abstract] [Full Text] [Related]
16. Aplasia of the bone marrow during mesantoin therapy; report of a fatal case. WITKIND E; WAID ME J Am Med Assoc; 1951 Oct; 147(8):757-9. PubMed ID: 14873554 [No Abstract] [Full Text] [Related]
17. [Granulocytopenic syndromes in mesantoin therapy]. BELSASSO M; BONIVENTO M Minerva Med; 1952 Oct; 43(79):558-62. PubMed ID: 13013023 [No Abstract] [Full Text] [Related]
18. [Bullous dermatoses cased by drug intolerance and bullous syndromes (significance and reciprocal relations)]. MUSUMECI V Minerva Dermatol; 1962 Nov; 37():382-6. PubMed ID: 13936896 [No Abstract] [Full Text] [Related]